Rapid Micro Biosystems (NASDAQ:RPID) Downgraded to Sell Rating by Wall Street Zen

Wall Street Zen cut shares of Rapid Micro Biosystems (NASDAQ:RPID) from a hold rating to a sell rating in a research note published on Sunday.

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Rapid Micro Biosystems in a report on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Rapid Micro Biosystems currently has a consensus rating of “Moderate Buy” and an average price target of $8.00.

Rapid Micro Biosystems Price Performance

Shares of NASDAQ RPID opened at $2.98 on Friday. The company has a 50 day simple moving average of $3.53 and a two-hundred day simple moving average of $3.33. Rapid Micro Biosystems has a fifty-two week low of $0.87 and a fifty-two week high of $4.50. The company has a market capitalization of $132.07 million, a price-to-earnings ratio of -2.95 and a beta of 1.33. The company has a debt-to-equity ratio of 0.42, a quick ratio of 2.95 and a current ratio of 4.23.

Rapid Micro Biosystems (NASDAQ:RPID) last posted its quarterly earnings results on Friday, November 7th. The company reported ($0.26) earnings per share for the quarter, hitting the consensus estimate of ($0.26). The company had revenue of $7.84 million for the quarter, compared to the consensus estimate of $7.60 million. Rapid Micro Biosystems had a negative return on equity of 73.90% and a negative net margin of 145.11%. Analysts expect that Rapid Micro Biosystems will post -1.1 EPS for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the business. Hudson Bay Capital Management LP bought a new stake in Rapid Micro Biosystems in the 3rd quarter worth about $38,000. Susquehanna International Group LLP boosted its holdings in shares of Rapid Micro Biosystems by 12.6% during the 3rd quarter. Susquehanna International Group LLP now owns 58,387 shares of the company’s stock valued at $195,000 after acquiring an additional 6,528 shares during the last quarter. Dimensional Fund Advisors LP boosted its holdings in shares of Rapid Micro Biosystems by 37.8% during the 3rd quarter. Dimensional Fund Advisors LP now owns 55,642 shares of the company’s stock valued at $186,000 after acquiring an additional 15,255 shares during the last quarter. Evernest Financial Advisors LLC grew its stake in shares of Rapid Micro Biosystems by 355.1% in the third quarter. Evernest Financial Advisors LLC now owns 200,234 shares of the company’s stock worth $669,000 after acquiring an additional 156,234 shares during the period. Finally, Vanguard Group Inc. raised its holdings in shares of Rapid Micro Biosystems by 6.7% during the third quarter. Vanguard Group Inc. now owns 965,018 shares of the company’s stock valued at $3,223,000 after purchasing an additional 60,655 shares during the last quarter. 52.60% of the stock is owned by institutional investors.

Rapid Micro Biosystems Company Profile

Rapid Micro Biosystems (NASDAQ: RPID) develops and commercializes automated microbial detection and contamination control solutions for the life sciences industry. Its flagship offering, the Growth Direct® System, leverages digital imaging and proprietary growth indicator plates to identify and count microorganisms more rapidly than traditional culture-based methods. The company’s technology platform is designed to streamline quality control workflows in pharmaceutical, biotechnology and vaccine manufacturing settings, helping clients reduce release times and improve operational efficiency.

In addition to the Growth Direct® System, Rapid Micro Biosystems offers an integrated suite of software and consumables that support automated data capture, analysis and reporting.